Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York
(Thomson Reuters ONE) -
DUBLIN, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA),
a late-stage clinical biotechnology company focused on the discovery,
development and commercialization of novel antibodies for the potential
treatment of diseases that involve amyloid or cell adhesion, announced that Tran
Nguyen, the Company's Chief Financial Officer, will be presenting at the
Oppenheimer 25(th) Annual Healthcare Conference on Thursday, December 11, 2014,
at 10:55 AM EST. The conference will be held at the Crowne Plaza Hotel in New
York.
A live webcast of the presentation can be accessed through the investor
relations section of the Company's website at www.prothena.com. Following the
live presentation, a reply of the webcast will be available on the Company's
website for 90 days.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology company focused
on the discovery, development and commercialization of novel antibodies for the
potential treatment of diseases that involve amyloid or cell adhesion. The
Company focuses on therapeutic monoclonal antibodies directed specifically to
disease-causing proteins and its antibody-based product candidates target a
number of potential indications including AL and AA forms of amyloidosis
(NEOD001), Parkinson's disease and other related synucleinopathies (PRX002) and
novel cell adhesion targets involved in psoriasis and other inflammatory
diseases (PRX003).
For more information, please visit the Company's web site at www.prothena.com.
CONTACT: Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Angela Bitting
925-202-6211, angela.bitting(at)prothena.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Prothena Corporation via GlobeNewswire
[HUG#1878364]
Unternehmensinformation / Kurzprofil:
Datum: 08.12.2014 - 22:05 Uhr
Sprache: Deutsch
News-ID 357993
Anzahl Zeichen: 2437
contact information:
Town:
DUBLIN
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 124 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
